Quest Diagnostics Granted CDC Contract to Sequence COVID-19 Gene Variants to Aid Public Health Response to COVID-19
- Monday, January 18, 2021, 7:15
- Environment
- Add a comment
SECAUCUS, N.J., Jan. 18, 2021 /PRNewswire/ — Quest Diagnostics (NYSE: DGX), the world’s leading provider of diagnostic information services, today announced that it has entered into an agreement with the Centers for Disease Control and Prevention (CDC) to provide genomic sequencing to…
About the Author
adminasapcorp has written 41828 stories on this site.